CompletedPhase 1NCT00003107
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Indiana University School of Medicine
- Principal Investigator
- Michael J. Robertson, MDIndiana University Melvin and Bren Simon Cancer Center
- Intervention
- recombinant interleukin-12(biological)
- Eligibility
- 18 years · All sexes
- Timeline
- 1997
Study locations (1)
- Indiana University Cancer Center, Indianapolis, Indiana, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003107 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.